Ken Griffin Astrazeneca PLC Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Astrazeneca PLC stock. As of the latest transaction made, Citadel Advisors LLC holds 1,685,500 shares of AZN stock, worth $115 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,685,500
Previous 2,692,600
37.4%
Holding current value
$115 Million
Previous $176 Million
29.78%
% of portfolio
0.02%
Previous 0.03%
Shares
31 transactions
Others Institutions Holding AZN
# of Institutions
1,418Shares Held
507MCall Options Held
8.14MPut Options Held
3.15M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$3.88 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.76 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.42 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.16 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.13 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $211B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...